San Diego, CA, United States of America

Alisher Khasanov

This inventor holds 1 USPTO granted patent. Top assignee: Jmb Capital Partners Lending, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alisher Khasanov. Retrieved from https://idiyas.com/inventor/alisher-khasanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alisher Khasanov: Inventor of a CD38 Antibody Drug Conjugate

Introduction

Alisher Khasanov is an inventor associated with San Diego, California. His listed patent work concerns a CD38 antibody drug conjugate, and he is credited with 1 patent.

Latest Patents

Khasanov’s listed patent is titled “CD38 Antibody Drug Conjugate.” The title identifies an invention involving an antibody-drug conjugate targeting CD38.

Career Highlights

Khasanov is associated with JMB Capital Partners Lending, LLC. The available information identifies his patent and company affiliation but does not provide further details about his role or career history.

Collaborations

Tong Zhu and Heyue Zhou are listed as Khasanov’s coworkers. The information provided does not specify their roles in the patent or any related research.

Conclusion

Alisher Khasanov’s recorded innovation is the CD38 antibody drug conjugate patent, alongside his association with JMB Capital Partners Lending, LLC.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…